The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials

OBJECTIVES: The role of anti-angiogenic tyrosine kinase inhibitors (AATKI) for patients with non-small-cell lung cancers (NSCLC) is uncertain. We conducted a comprehensive meta-analysis to assess the overall utility of adding AATKI to chemotherapy. MATERIALS AND METHODS: We included 15 randomized co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer
Main Authors: Li, Bob T., Barnes, Tristan A., Chan, David L., Naidoo, Jarushka, Lee, Adrian, Khasraw, Mustafa, Marx, Gavin M., Kris, Mark G., Clarke, Stephen J., Drilon, Alexander, Rudin, Charles M., Pavlakis, Nick
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5441998/
https://ncbi.nlm.nih.gov/pubmed/27987583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2016.10.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados